Data

Infections and immunity board – funding decisions

Information about applications considered and those awarded grants.

From:
MRC
Published:

Documents

Infections and immunity board - 14-15 October 2020 (Microsoft Excel spreadsheet)

, 31 KB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@ukri.org.

Infections and immunity board - 18-20 June 2020 (Microsoft Excel spreadsheet)

, 42 KB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@ukri.org.

Infections and immunity board - 25-26 February 2020 (Microsoft Excel spreadsheet)

, 19 KB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@ukri.org.

Infections and immunity board - 16-17 October 2019 (Microsoft Excel spreadsheet)

, 19 KB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@ukri.org.

Infections and immunity board - 18 June 2019 (Microsoft Excel spreadsheet)

, 20 KB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@ukri.org.

Infections and immunity board - 28 January 2019 (Microsoft Excel spreadsheet)

, 45 KB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@ukri.org.

Infections and immunity board - 16-17 October 2018 (Microsoft Excel spreadsheet)

, 21 KB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@ukri.org.

Infections and immunity board - 22-23 June 2018 (Microsoft Excel spreadsheet)

, 20 KB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@ukri.org.

Infections and immunity board - 27-28 October 2017 (Microsoft Excel spreadsheet)

, 23 KB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@ukri.org.

Infections and immunity board - 22-23 June 2017 (Microsoft Excel spreadsheet)

, 41 KB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@ukri.org.

Infections and immunity board - 16 February 2017 (Microsoft Excel spreadsheet)

, 13 KB

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@ukri.org.

Details

Funding decision information showing applications considered and those that were awarded grants.

Page last updated: 2 December 2021

NOTE Council web content is being transitioned to this website – let us know if you have feedback or would like to help us test new developments.